V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008732 | 260005791 | 1.83 | 114.6 | Curative (C) | 2014-08-15 | 2014-08-29 | DA-EPOCH-R | N | N | 260028506 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260008733 | 260005791 | 1.7 | 87 | Disease modification (D) | 2018-11-02 | 2018-11-16 | Capecitabine (14 day) + Irinotecan | Y | N | 260028506 | RITUXIMAB |
| 260008734 | 260015559 | 1.76 | 107.4 | Disease modification (D) | 2016-08-16 | 2016-08-20 | R Chlorambucil | N | N | 260028515 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008735 | 260005792 | 1.7 | 103.3 | null | 2013-04-03 | 2013-04-23 | Chlorambucil | 2 | N | 260028516 | RITUXIMAB |
| 260008736 | 260012017 | null | 90.4 | null | null | 2015-09-23 | CHOP - 21 days | null | null | 260028517 | RCEOP |
| 260008737 | 260005793 | 1.8 | 77.7 | Palliative (P) | 2017-02-14 | 2017-03-09 | Rituximab | N | N | 260028518 | RITUXIMAB |
| 260008738 | 260005793 | 1.8 | 56.3 | Unknown (U) | 2018-12-03 | 2018-12-03 | CHOP - 21 days | 02 | N | 260028518 | RITUXIMAB |
| 260008739 | 260005793 | 1.6 | 80.7 | Curative (C) | null | 2015-01-16 | GALLIUM TRIAL | N | N | 260028518 | RITUXIMAB |
| 260008740 | 260005794 | 1.74 | null | Palliative (P) | 2016-10-28 | 2016-11-05 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | N | N | 260028523 | RITUXIMAB |
| 260008741 | 260005795 | 1.65 | 63 | Curative (C) | 2013-11-30 | 2013-12-03 | ABVD | N | N | 260028524 | TRIAL |
| 260008742 | 260005796 | 0 | 122.7 | null | 2013-03-30 | 2013-04-02 | Oxaliplatin + Modified de Gramont | 02 | N | 260028527 | BENDAMUSTINE |
| 260008743 | 260005796 | 1.84 | 97 | Palliative (P) | 2016-10-29 | 2016-11-05 | Rituximab | 02 | N | 260028527 | OXALIPLATIN + MDG |
| 260008744 | 260005797 | 1.64 | 50.3 | Disease modification (D) | 2015-01-01 | 2015-01-01 | GALLIUM TRIAL | 2 | N | 260028529 | IVE-R |
| 260008745 | 260005798 | null | 0 | null | 2018-04-20 | 2018-05-13 | Rituximab | N | N | 260028530 | RITUXIMAB |
| 260008746 | 260005799 | null | 87.6 | Curative (C) | 2018-03-18 | 2018-03-30 | Rituximab | 2 | N | 260028536 | BENDAMUSTINE |
| 260008747 | 260005799 | 1.8 | 129.7 | Curative (C) | 2015-10-30 | 2015-10-30 | Rituximab | 02 | N | 260028536 | BENDAMUSTINE |
| 260008748 | 260015561 | 1.65 | 65.5 | Curative (C) | 2016-12-25 | 2017-01-08 | Rituximab | 2 | N | 260028539 | NOT MATCHED |
| 260008749 | 260015561 | 1.8 | 97.5 | Palliative (P) | 2017-02-09 | 2017-02-14 | Rituximab | Y | N | 260028539 | RITUXIMAB |
| 260008750 | 260015561 | null | 95.2 | Curative (C) | null | 2014-01-11 | Rituximab | 02 | N | 260028539 | BENDAMUSTINE |
| 260008751 | 260005800 | 1.73 | 72 | Curative (C) | 2014-06-30 | 2014-07-18 | Rituximab | 02 | N | 260028543 | RITUXIMAB |
| 260008752 | 260005800 | 0 | 78.4 | Curative (C) | 2014-06-02 | 2014-06-03 | Rituximab | N | N | 260028543 | ETOPOSIDE |
| 260008753 | 260005801 | 1.69 | 96 | null | 2017-04-14 | 2017-04-25 | CHOP - 21 days | N | null | 260028548 | RITUXIMAB |
| 260008754 | 260005802 | 1.52 | 93.8 | Palliative (P) | 2017-07-04 | 2017-07-07 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | N | N | 260028549 | RITUXIMAB |
| 260008755 | 260005802 | 1.64 | 87.5 | Disease modification (D) | 2017-11-09 | 2017-11-13 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260028549 | RITUXIMAB |
| 260008756 | 260005803 | null | 68.899 | Palliative (P) | 2018-04-19 | 2018-04-25 | MPV (cycle 5-9) - maintenance | N | N | 260028551 | RITUXIMAB |
| 260008757 | 260005803 | 1.77 | 94.8 | Palliative (P) | 2018-08-01 | 2018-08-05 | INTERFERON | N | N | 260028551 | RITUXIMAB |
| 260008758 | 260005804 | 1.83 | 92.8 | Palliative (P) | 2014-12-04 | 2014-12-09 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028555 | GEMCITABINE + VINORELBINE |
| 260008759 | 260005804 | 1.62 | 66.3 | Palliative (P) | 2016-04-23 | 2016-04-26 | Rituximab | 02 | N | 260028555 | RCEOP |
| 260008760 | 260005805 | 1.65 | 53 | Palliative (P) | null | 2013-07-04 | Rituximab | N | N | 260028564 | RITUXIMAB |
| 260008761 | 260012025 | 1.89 | null | Not known (9) | 2017-03-23 | 2017-03-24 | Rituximab | 02 | N | 260028565 | CISPLATIN + ETOPOSIDE |
| 260008762 | 260005806 | null | null | null | 2015-06-04 | 2015-06-04 | CAPECITABINE + OXALIPLATIN | N | null | 260028568 | CHOP |
| 260008763 | 260005806 | 1.7 | 85 | Palliative (P) | 2013-05-26 | 2013-06-19 | Rituximab | 01 | N | 260028568 | BENDAMUSTINE |
| 260008764 | 260005806 | 1.65 | 92 | null | null | 2013-09-08 | BENDAMUSTINE | N | null | 260028568 | BENDAMUSTINE |
| 260008765 | 260005806 | 1.83 | 78.6 | Disease modification (D) | 2013-04-13 | 2013-04-14 | Rituximab (Maintenance) | N | N | 260028568 | RITUXIMAB |
| 260008766 | 260005806 | 1.64 | 71.4 | Curative (C) | 2015-04-25 | 2015-05-28 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028568 | RITUXIMAB |
| 260008767 | 260005807 | 1.75 | 79.999 | Curative (C) | 2013-03-15 | 2013-04-04 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | null | 260028574 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260008768 | 260005807 | 1.82 | 73 | Palliative (P) | 2015-04-08 | 2015-11-13 | Mitomycin Intravesical | 02 | N | 260028574 | PACIFICO TRIAL |
| 260008769 | 260005808 | null | null | Palliative (P) | 2016-07-14 | 2016-07-21 | CYCLOPHOSPHAMIDE | 01 | N | 260028577 | BENDAMUSTINE |
| 260008770 | 260005808 | 1.8 | null | Disease modification (D) | 2013-05-16 | 2013-05-23 | Bendamustine + prednisolone | N | N | 260028577 | GEMCITABINE |
| 260008771 | 260005809 | 1.74 | 71.9 | Palliative (P) | 2013-03-23 | 2013-03-23 | Rituximab | N | N | 260028579 | PACIFICO TRIAL |
| 260008772 | 260005809 | 1.79 | 57 | Curative (C) | 2018-05-26 | 2018-05-30 | ABVD | N | N | 260028579 | RITUXIMAB |
| 260008773 | 260005810 | 1.71 | 85.5 | Curative (C) | 2014-06-12 | 2014-07-04 | Rituximab | N | N | 260028583 | RITUXIMAB |
| 260008774 | 260012030 | 1.72 | null | Curative (C) | 2013-02-19 | 2013-02-21 | Hydroxycarbamide | N | N | 260028584 | PMITCEBO |
| 260008775 | 260005811 | null | 85 | Palliative (P) | null | 2013-11-12 | Rituximab | N | N | 260028585 | RITUXIMAB |
| 260008776 | 260012031 | null | 85 | Palliative (P) | 2014-10-04 | 2014-10-12 | CHOP - 21 days | N | N | 260028587 | RITUXIMAB |
| 260008777 | 260005812 | 1.88 | 74 | Disease modification (D) | 2017-05-22 | 2017-05-25 | null | 02 | N | 260028592 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008778 | 260005812 | 1.83 | 88.1 | Curative (C) | 2016-02-15 | 2016-02-20 | Bendamustine + prednisolone | 2 | N | 260028592 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008779 | 260005813 | 1.66 | 64 | Curative (C) | null | 2013-01-26 | Cytarabine intrathecal | N | N | 260028595 | FLAG |
| 260008780 | 260005814 | 1.81 | 88.8 | Curative (C) | 2013-08-20 | 2013-08-20 | R Chlorambucil | 02 | N | 260028598 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008781 | 260012033 | 1.73 | 56 | Curative (C) | 2017-08-18 | 2017-08-20 | Trial Unspecified | 2 | N | 260028600 | CISPLATIN + GEMCITABINE + RITUXIMAB |